dc.contributor.author | Boulyjenkov, Victor | en |
dc.contributor.author | Schapper, Cathy | en |
dc.contributor.author | WHO Human Genetics Programme | en |
dc.coverage.spatial | Geneva | |
dc.date.accessioned | 2012-06-16T14:49:10Z | |
dc.date.available | 2012-06-16T14:49:10Z | |
dc.date.created | 2007 | en |
dc.date.issued | 2007 | en |
dc.identifier.isbn | 9789241595469 | |
dc.identifier.uri | https://iris.who.int/handle/10665/43669 | |
dc.description | "Preparation of this report was undertaken by Human Genetics, headed by Victor Boulyjenkov. Cathy Schapper (Monash University) had principal responsibility for researching, writing and editing the report ..."--Acknowledgements | en |
dc.description | 67 p. | en |
dc.language.iso | en | en |
dc.publisher | World Health Organization | |
dc.publisher | World Health Organization | |
dc.subject.mesh | Pharmacogenetics | en |
dc.subject.mesh | Patient Rights | en |
dc.subject.mesh | Socioeconomic Factors | en |
dc.subject.mesh | Ethics, Pharmacy | en |
dc.subject.mesh | Legislation, Drug | en |
dc.subject.mesh | Developing Countries | en |
dc.subject.other | Medical Technology and Radiation Medicine | en |
dc.title | The ethical, legal and social implications of pharmacogenomics in developing countries : report of an international group of experts | en |
dc.subject.meshqualifier | ethics legislation | en |